Shah S, Sesti AM, Copley-Merriman K, Plante M. Quality of life terminology included in package inserts for US approved medications. Qual Life Res. 2003 Dec 1;12(8):1107-17.
Fehnel SE, McLeod LD, Hogue SL. The responsiveness of the motivation and energy inventory (MEI). Poster presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2003.
Williams VS, McLeod LD, Fehnel SE. Psychometrics: processes and applications. Presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2003.
Backhouse ME, Meads D, Doward LC, McKenna SP. The use of discrete choice analysis to assist with the interpretation of quality of life scores. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):787.
Kroutil L, Weimer B, Candrilli SD, Smith R, Rachal V. An automated population based framework for integrating estimates of substance abuse treatment needs: implemented for the state of Missouri. Poster presented at the 18th Annual Conference of the American Evaluation Association; November 2003.
DeMuro-Mercon CJ, Gonce C, Lewis SA, Altarac D, O'Keefe S, Bachmann S. The electronic patient reported outcome (e-PRO): compliance procedures and regulatory applicability. Poster presented at the Drug Information Association; October 2003.
Mosis G, Gutierrez LP, Dieleman J, Castellsague J, Sturkenboom M. No changes in channeling of COX-2 Specific inhibitors in the first three years after marketing. Poster presented at the ISoP Annual Conference ‘Pharmacovigilance in Clinical Practice’; October 2003. Marrakech, Morocco. [abstract] Pharmacoepidemiol Drug Saf. 2003 Oct; 12(S2):S243.
Williams LK, Pladevall-Vila M, Fendrick AM, Lafata JE, McMahon LF. Differences in the reporting of care-related patient injuries to existing reporting systems. Jt Comm J Qual Patient Saf. 2003 Sep;29(9):460-7.
Chromy J, Odom DM, Eyerman J, McNeeley M, Hughes A. The effect of interviewer experience on the interview process in the national survey on drug use and health. Poster presented at the Proceedings of the American Statistical Association, Section on Survey Research Methods; August 2003. San Francisco, CA.
Hicks KA. Using computer simulation modeling for process evaluation. Presented at the National Environmental Monitoring Conference; July 2003.
Hicks KA. A study of the response times of state public health labs in a chemical terrorism incident using a computer simulation model. Poster presented at the Public Health Labs Chemical Terrorism Workshop; June 2003.
Fehnel SE, McLeod LD, Williams VS. Combining qualitative and quantitative techniques in the development of patient-reported outcome measures. Presented at the Eighth Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 2003.
Michels KB, Rothman KJ. Update on unethical use of placebos in randomised trials. Bioethics. 2003 Apr;17(2):188-204.
Clark MJ. Opportunities for pharmacists in industry: outcomes research. Presented at the International Society for Pharmacoeconomics and Outcomes Research UM Student Chapter; March 2003.
Fehnel SE. Developing strategies for the measurement of patient-reported outcomes. Poster presented at the Fourth Annual Phase IV and Peri-Approval Clinical Research Conference conducted by Barnett International; February 1, 2003. Philadelphia, PA.
Earnshaw SR, Dennett SL. Integer/linear mathematical programming models: a tool for allocating healthcare resources. Pharmacoeconomics. 2003 Jan 1;21(12):839-51.
McLeod L, Lewis C, Thissen D. A Bayesian method for the detection of item preknowledge in computerized adaptive testing. Appl Psychol Meas. 2003 Jan 1;27(2):121-37.
Arana A, Broeckmans AW. Validity of epidemiological research conducted following Good Clinical Practice Guidelines. Presented at the 19th International Conference on Pharmacoepidemiology; 2003.
DeMuro-Mercon CJ, Gonce C, Lewis SA. The electronic patient reported outcome (e-PRO) work for diary and questionnaire data. Presented at the Drug Information Association; 2003.
DeMuro-Mercon CJ, Lewis SA, Gonce C. Old relationships, new technologies: partnering with your clinical sites to make an electronic patient reported outcome (e-PRO) work for diary and questionnaire data. Poster presented at the Drug Information Association; 2003.
Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.
Tuells A, Arana A, Perez-Gutthann S, García-Rodríguez LA. El Proyecto BIFAP. Inv Clin Farm. 2003;0:25-6.
Lovas K, Kalo Z, McKenna SP, Whalley D, Pentek M, Genti G. Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary. Health Policy (New York). 2003 Jan 1;63(1):20.
Humphries SE, Hawe E, Dhamrait S, Miller GJ, Talmud PJ. In search of genetic precision. Lancet. 2003;361(9372):1908-1909.
Rothman KJ. A pictorial representation of confounding in epidemiologic studies. J Chronic Dis. 1975 Feb;28(2):101-8.
Rothman KJ. Computation of exact confidence intervals for the odds ratio. Int J Biomed Comput. 1975 Jan;6(1):33-9.